00:33:56 EDT Fri 26 Apr 2024
Enter Symbol
or Name
USA
CA



Cannabis Summary for Sept. 23, 2022

2022-09-23 19:17 ET - Market Summary

This item is part of Stockwatch's value added news feed and is only available to Stockwatch subscribers.

Here is a sample of this item:

by Stockwatch Business Reporter

The S&P/TSX Cannabis Index added a fraction to 37.07, while the CSE Composite Index lost 12.84 to 248.91. Canadian cannabis sales climbed to a record $394.8-million in July, according to data released this morning by Statistics Canada. This was up from sales of $377.9-million in June, the previous monthly record, and up from $335.1-million in July of last year.

Canada's latest market, Ontario, accounted for two-fifths of the total, with July sales of $159.4-million. This represented a year-over-year increase of 30 per cent, markedly above the nationwide increase of 17 per cent. The outsized jump reflects a rapid rise in the province's store count starting in early 2021. As of July, there were nearly 1,500 cannabis stores in Ontario, up from 1,000 a year earlier (and from just 100 in July, 2020).

The green rush has slowed to a relative trickle this year, amid rising concern that Ontario -- or at least the parts of it that retailers are drawn to -- cannot support so many stores. The trend is especially prominent in Toronto, home to over 400 of the province's current store count of 1,614. "Toronto's pot shop reckoning is here -- industry watchers predict up to a third of our stores will close," blared the Toronto Star on Sept. 3. Meanwhile, some previously planned stores will simply not open: Data from the Ontario regulator show that 31 would-be stores in the Greater Toronto Area have cancelled their applications this year (January through August), compared with just three in all of 2021.

The remainder is available to Stockwatch subscribers.
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

© 2024 Canjex Publishing Ltd. All rights reserved.


Reader Comments - Comments are open to paying subscribers of Stockwatch and unmoderated, although libelous remarks, obscene language and impersonations may be deleted. Opinions expressed do not necessarily reflect the views of Stockwatch.
For information regarding Canadian libel law, please view the University of Ottawa's FAQ regarding Defamation and SLAPPs.


Comments for this item are closed